Platelet reactivity to GPVI is enhanced in patients with diabetes and obesity [34,35], and platelet GPVI surface expression was significantly increased in patients with acute coronary syndrome, TIA, and stroke [36,37]. This evidence concerns the gene GP6 and obesity due to melanocortin 4 receptor deficiency.